NFE2L2 and neoplasm: In HNC, where oxidative stress is inherently elevated due to metabolic reprogramming and therapy-induced ROS, Nrf2-mediated reinforcement of ferroptosis resistance provides a critical advantage for tumor progression and therapy evasion [41,51].